Release Date: December 10, 2022
Expiration Date: March 2, 2023
Activity Overview
This educational activity is an archive of the live virtual presentation held on December 9, 2022.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This activity is directed toward hematologists, nurses, and other healthcare professionals involved in the treatment of patients with CKD in anemia.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Discuss the burden of anemia on patients with chronic kidney disease
- Review the pathophysiology of anemia in chronic kidney disease
- Implement guideline-based recommendations for the evaluation of anemia in patients with chronic kidney disease
- Formulate individualized management plans for patients with anemia and chronic kidney disease.
Steven Fishbane, MD
Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Hofstra University
Chief of Nephrology
Northwell Health
Great Neck, NY
Disclosures: Grant/Research Support: AstraZeneca, GSK; Consultant: AstraZeneca, GSK
Ellie Kelepouris, MD, FACP, FAHA
Professor of Clinical Medicine
Perelman School of Medicine
University of Pennsylvania
Director of Outpatient Dialysis Programs
Penn Medicine
Philadelphia, PA
Disclosures: Grant/Research Support: CAR-HF Vifor Pharma; Consultant: AstraZeneca, Bayer, Boehringer Ingelheim-Lilly, Vifor Pharma
Nupur Nippun Uppal, MD
Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Hofstra University
Nephrologist
Northwell Health
Great Neck, NY
Disclosures: Nupur Nippun Uppal, MD has no relevant financial relationships with ineligible companies.
Jay B. Wish, MD
Medical Director
Outpatient Dialysis
Indiana University Hospital
Chief Medical Officer, Dialysis
IU Health
Professor of Clinical Medicine
Indiana University School of Medicine
Indianapolis, IN
Disclosures: Consultant: Akebia Therapeutics, Amgen, AstraZeneca, CSL Behring, Disc Medicine, FibroGen, GSK, Otsuka, Rockwell Medical, Vifor Pharma; Speakers’ Bureau: Akebia Therapeutics, AstraZeneca
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
